Shiang Ding Targets US Market With Healthy Herbal Beverage Alternatives
TAIPEI, Nov. 14, 2022 /PRNewswire/ -- Shiang Ding Food Co. (Shiang Ding), one of Taiwan's premier food wholesalers, announced new plans to expand access to healthy, herbal tea and coffee alternatives in the US market via its Tang Ding brand of brown sugar tea bricks. This announcement comes amid an ever-growing interest in complementary and alternative medicinal solutions in...
AIRS Medical showcases award-winning MRI enhancement AI solution at RSNA 2022
SEOUL, South Korea, Nov. 14, 2022 /PRNewswire/ -- AIRS Medical, Inc., a leading medical AI solution provider, announced its participation in the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA 2022), the world's leading annual imaging forum at McCormick Place in Chicago held from November 27 to 30th. At RSNA booth #4744, AIRS Medical...
The World’s First ETa-specific Monoclonal Antibody: Gmax Biopharm’s GMA131 Approved by the US FDA for Clinical Study on (DKD) Diabetic Kidney Disease
HANGZHOU, China, Nov. 14, 2022 /PRNewswire/ -- Gmax Biopharm LLC. announced today that its application of investigation of New Drug (IND) for GMA131 injection, the first global ETa-specific monoclonal antibody, was approved by the US FDA on Nov 11, 2022 for clinical study on diabetic kidney disease (DKD). Dr. Shuqian Jing, Founder and Chairman of Gmax Biopharm, said, "GMA131...
NuraLogix Researchers Announce the Capability to Assess Type 2 Diabetes and Blood Biomarker Health Issues Using Any Video-Enabled Device
Facial blood flow patterns can predict a person's risk of pre-diabetes in just 30 seconds LAS VEGAS, Nov. 14, 2022 /PRNewswire/ -- Researchers at NuraLogix, a global pioneer of contactless health monitoring through its patented Transdermal Optical Imaging (TOI™) technology, has announced that it is adding the ability to perform metabolic and blood biomarker health risk assessments for various...
EMOTIV Partners with X-trodes to Launch New Medical-Grade, At-Home Solution for Brain Monitoring Research
Wearable Electrode Patches Provide Unprecedented Accuracy for Researchers Measuring Brain and Physiological Signals Outside the Lab, Expanding Possibilities for Real-World Clinical Studies SAN FRANCISCO and HERZLIYA, Israel, Nov. 14, 2022 /PRNewswire/ -- EMOTIV, a bioinformatics company advancing understanding of the human brain using electroencephalography (EEG), and X-trodes, a company bringing wireless medical-grade monitoring solutions to the home environment,...
Meihua International Medical Technologies Co., Limited Reports Unaudited 2022 First Half Financial Results
YANGZHOU, China, Nov. 14, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Limited ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today reported its unaudited financial results for the six months ended June 30, 2022. First Half 2022 Unaudited Financial Highlights ...
RedHill Accelerates Opaganib’s Nuclear Radiation Protection Program – Positive Data Published
Strong preclinical data, recently published in the International Journal of Molecular Sciences, from eight U.S government-funded in-vivo opaganib studies, supports opaganib's potential as a nuclear radiation injury therapeutic for homeland security material threat medical countermeasures (MCM) and for antitumor radiotherapy As an oral, small molecule pill that is highly stable with...
SENTINEL DIAGNOSTICS LAUNCHES SENTINAT® 200, THE FULLY AUTOMATED SAMPLE TO RESULT SYSTEM FOR THE DIAGNOSIS OF VIRAL INFECTIONS
MILAN, Nov. 14, 2022 /PRNewswire/ -- Sentinel CH. SpA today announced the launch of SENTiNAT® 200, the fully automated sample to result system, and STAT-NAT® SN200 Real-Time PCR assays for the quantitative detection of 10 viruses. SENTiNAT® 200 and STAT-NAT® SN200 kits represent the ideal solution for mid to large throughput laboratories...
Mednovation Entered Into Strategic Cooperation With LSI
SHANGHAI, Nov. 14, 2022 /PRNewswire/ -- Mednovation is very pleased to announce that it has entered into a cooperation agreement with Life Science Intelligence, Inc. ("LSI") to promote the parties to the Medtech industry worldwide, and to cooperate with each other to support development and innovation in the Chinese Medtech market. Under the agreed arrangement, which is effective as...
Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China
SHANGHAI, Nov. 14, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the Center for Drug Evaluation ("CDE") has approved its Investigational New Drug ("IND") application supporting its pivotal phase III clinical trial of MVA-BN RSV vaccine against respiratory syncytial virus (RSV) in adults in mainland China. MVA-BN RSV, is being developed for the prevention of respiratory syncytial virus (RSV) in...
